Laboratory Assessment of Patients with Suspected Rheumatic Musculoskeletal Diseases: Challenges and Pitfalls

被引：6

作者：

Carubbi, Francesco ^{[1
,2
]}

Alunno, Alessia ^{[3
]}

Cipriani, Paola ^{[1
]}

Bistoni, Onelia ^{[3
]}

Scipioni, Rosa ^{[2
]}

Liakouli, Valiki ^{[1
]}

Ruscitti, Piero ^{[1
]}

Berardicurti, Onorina ^{[1
]}

Di Bartolomeo, Salvatore ^{[1
]}

Gerli, Roberto ^{[3
]}

Giacomelli, Roberto ^{[1
]}

机构：

[1] Univ Aquila, Sch Med, Dept Biotechnol & Appl Clin Sci, Rheumatol Unit, Laquila, Italy

[2] ASL1 Avezzano Sulmona Aquila, Dept Med, Laquila, AQ, Italy

[3] Univ Perugia, Dept Med, Rheumatol Unit, Perugia, PG, Italy

来源：

CURRENT RHEUMATOLOGY REVIEWS | 2019年 / 15卷 / 01期

关键词：

Laboratory; assessment; rheumatology; biomarkers; pathogenesis; mechanistic value; ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES; CITRULLINATED PEPTIDE ANTIBODIES; INTERNATIONAL CONSENSUS STATEMENT; SYSTEMIC-LUPUS-ERYTHEMATOSUS; PRIMARY SJOGRENS-SYNDROME; SYNOVIAL-FLUID; CLASSIFICATION CRITERIA; BACTERIAL-INFECTION; RHEUMATOLOGY/EUROPEAN LEAGUE; PROCALCITONIN MEASUREMENT;

D O I：

10.2174/1573397114666180320113603

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Current patient care in rheumatology relies primarily on a combination of traditional clinical assessment and standard laboratory tests. Investigators seek to discover new biomarkers and novel technologies to boost the research in this field. Mechanistic biomarkers such as cytokines, cell types, antibodies, signaling molecules, are rooted in the mechanism underlying the disease and can guide the clinical management of the disease. Conversely, descriptive biomarkers are by-products of the disease process, depict the state of a disease but are not involved in its pathogenesis. In this article, we reviewed the field of common laboratory biomarkers in rheumatology, highlighting both their descriptive or mechanistic value as well as their role in clinical practice.

引用

收藏

页码：27 / 43

页数：17

相关论文

共 153 条

[1] International recommendations for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies [J].

Agmon-Levin, Nancy ;

Damoiseaux, Jan ;

Kallenberg, Cees ;

Sack, Ulrich ;

Witte, Torsten ;

Herold, Manfred ;

Bossuyt, Xavier ;

Musset, Lucille ;

Cervera, Ricard ;

Plaza-Lopez, Aresio ;

Dias, Carlos ;

Sousa, Maria Jose ;

Radice, Antonella ;

Eriksson, Catharina ;

Hultgren, Olof ;

Viander, Markku ;

Khamashta, Munther ;

Regenass, Stephan ;

Coelho Andrade, Luis Eduardo ;

Wiik, Allan ;

Tincani, Angela ;

Ronnelid, Johan ;

Bloch, Donald B. ;

Fritzler, Marvin J. ;

Chan, Edward K. L. ;

Garcia-De la Torre, I. ;

Konstantinov, Konstantin N. ;

Lahita, Robert ;

Wilson, Merlin ;

Vainio, Olli ;

Fabien, Nicole ;

Sinico, Renato Alberto ;

Meroni, Pierluigi ;

Shoenfeld, Yehuda .

ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (01) :17-23

[2] Decrease of anti-cyclic citrullinated peptide antibodies and rheumatoid factor following anti-TNFα therapy (infliximab) in rheumatoid arthritis is associated with clinical improvement [J].

Alessandri, C ;

Bombardieri, M ;

Papa, N ;

Cinquini, M ;

Magrini, L ;

Tincani, A ;

Valesini, G .

ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 (10) :1218-1221

[3] Therapeutic implications of autoantibodies in rheumatoid arthritis [J].

Aletaha, Daniel ;

Blueml, Stephan .

RMD OPEN, 2016, 2 (01)

[4]

[Anonymous], 2015, FRONT IMMUNOL, DOI DOI 10.3389/FIMMU.2015.00412

[5] β2-glycoprotein-1 autoantibodies from patients with antiphospholipid syndrome are sufficient to potentiate arterial thrombus formation in a mouse model [J].

Arad, Ariela ;

Proulle, Valerie ;

Furie, Richard A. ;

Furie, Barbara C. ;

Furie, Bruce .

BLOOD, 2011, 117 (12) :3453-3459

[6] Analysing cell-free plasma DNA and SLE disease activity [J].

Atamaniuk, Johanna ;

Hsiao, Yu-Yang ;

Mustak, Monika ;

Bernhard, Duhm ;

Erlacher, Ludwig ;

Fodinger, Manuela ;

Tiran, Beate ;

Stuhlmeier, Karl M. .

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2011, 41 (06) :579-583

[7] Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework [J].

Atkinson, AJ ;

Colburn, WA ;

DeGruttola, VG ;

DeMets, DL ;

Downing, GJ ;

Hoth, DF ;

Oates, JA ;

Peck, CC ;

Schooley, RT ;

Spilker, BA ;

Woodcock, J ;

Zeger, SL .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (03) :89-95

[8] Epstein-Barr virus and rheumatoid arthritis [J].

Balandraud, N ;

Roudier, J ;

Roudier, C .

AUTOIMMUNITY REVIEWS, 2004, 3 (05) :362-367

[9] Increased levels of circulating DNA in patients with systemic autoimmune diseases: A possible marker of disease activity in Sjogren's syndrome [J].

Bartoloni, E. ;

Ludovini, V. ;

Alunno, A. ;

Pistola, L. ;

Bistoni, O. ;

Crino, L. ;

Gerli, R. .

LUPUS, 2011, 20 (09) :928-935

[10] Clinical review 167 -: Procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis:: A journey from calcitonin back to its precursors [J].

Becker, KL ;

Nylén, ES ;

White, JC ;

Müller, B ;

Snider, RH .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (04) :1512-1525

← 1 2 3 4 5 6 7 8 9 10 →